ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
January 09, 2025 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
November 13, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
November 07, 2024 08:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
October 08, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
August 13, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
August 07, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
July 09, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, July 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
June 05, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
June 04, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, June 04, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
May 14, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...